Therefore, continuous and concomitant low-grade inflammation, insulin resistance, glucose intolerance cytokines (resistin, TNF-α, and IL-6), FFAs, and additional vascular elements released from the visceral adiposity may improve cancer risk and establish a suitable microenvironment for cancer progression. The gene discussed is RETN; the disease is Glucose intolerance.